K. Sheng Lim
Professor in glaucoma studies
Professor Kin Sheng Lim is the clinical lead in glaucoma service and the ophthalmology departmental lead for research. He is also the professor of ophthalmology (glaucoma studies), School of Life Course Sciences, Faculty of Life Sciences and Medicine, King's College London (KCL).
He qualified from University of Leicester Medical School in 1991 and obtained his doctorate degree (MD- research) from University College London in 2001. Most of his general ophthalmology training was done at Moorfields Eye Hospital, Western Eye Hospital and Royal Free Hospital in London during his residency program. In 1997, he spent more than two years at Institute of Ophthalmology, Moorfields Eye Hospital and University of Brighton researching into the surgical treatment of glaucoma towards his doctorate degree.
He subsequently received fellowship training in glaucoma training at Moorfields Eye Hospital for over two years. In 2001, he was awarded a scholarship from the International Glaucoma Association to undergo further specialist research and clinical training for one year in glaucoma at the Mayo Clinic in Rochester, Minnesota, USA.
He has been a fellow of the Royal College of Ophthalmologists in the UK since 1996 and is a member of numerous national and international ophthalmological associations.
His clinical interests are in the treatment of complex glaucoma as well as high-volume small incision cataract surgery.
He is the director of the KCL Frost Ophthalmology Research Department at St Thomas’ Hospital and supervises a team of 14 research staff. He is currently conducting a number of clinical trials into pathogenesis and new treatment options for glaucoma.
Education and training
- MD 2001 Doctorate in Medicine (University College London)
- FRCOphth 1996 Fellow of Royal College of Ophthalmologists
- MB ChB 1991 Bachelor of Medicine & Surgery (Leicester University).
He is currently the research lead for the ophthalmology department and supervises a team of seven researchers.
He is the principal and chief investigator for eight ongoing clinical trials concentrating in the pathogenesis and treatment of glaucoma.
He also collaborates with a bioengineering group at Imperial College London working on new diagnosis and treatment devices for glaucoma.
Last updated: May 2022